IBM Watson Health and MAP Health Management Partner to Curb Incidence of Substance Abuse Relapse in the United States

MAP Health Management and IBM (NYSE: IBM) Watson Health have announced a partnership that aims to address the pervasive problem of relapse among Americans suffering from Substance Use Disorder, a chronic disease. MAP will integrate Watson cognitive technologies into the MAP Recovery Network Platform to enhance the platform's existing capabilities around patient risk models.
Source: eHealth News EU - Category: Information Technology Tags: Featured IBM Healthcare Business and Industry Source Type: news